Bloodworks is located in Seattle, WA. The organization was established in 1980. According to its NTEE Classification (E61) the organization is classified as: Blood Banks, under the broad grouping of Health Care and related organizations. As of 06/2022, Bloodworks employed 973 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Bloodworks is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 06/2022, Bloodworks generated $134.3m in total revenue. This represents a relatively dramatic decline in revenue. Over the past 7 years, the organization has seen revenues fall by an average of (4.2%) each year. All expenses for the organization totaled $136.4m during the year ending 06/2022. As we would expect to see with falling revenues, expenses have declined by (3.9%) per year over the past 7 years. You can explore the organizations financials more deeply in the financial statements section below.
Since 2016, Bloodworks has awarded 59 individual grants totaling $6,204,589. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
SAVING LIVES THROUGH RESEARCH, INNOVATION, EDUCATION & EXCELLENCE IN BLOOD, MEDICAL & LAB SERVICES.
Describe the Organization's Program Activity:
Part 3 - Line 4a
RECRUIT DONORS, COLLECT, TEST, PROCESS AND FRACTIONATE WHOLE BLOOD AND COMPONENTS INTO TRANSFUSION READY PRODUCTS (WHOLE BLOOD, RED BLOOD CELLS, PLATELETS, PLASMA AND CRYOPRECIPITATE) FOR USE IN NEARLY 90 HOSPITALS, PRIMARILY LOCATED IN THE PACIFIC NORTHWEST.
WE ARE A RESEARCH INSTITUTE WITH OVER 75 YEARS OF RESEARCH AND DISCOVERIES. BLOODWORKS SCIENTISTS HAVE TRANSFORMED PATIENT CARE WITH BREAKTHROUGHS IN TRANSFUSION MEDICINE, BLOOD BIOLOGY, BLOOD STORAGE, CANCER THERAPIES, ORGAN TRANSPLANTATION, AND TREATMENT OF CLOTTING DISORDERS. BLOODWORKS' SCIENTISTS CAN BE FOUND IN MEDICAL SCHOOLS AND AT SCIENTIFIC FORUMS SHARING THE LATEST BLOOD SCIENCE WITH DOCTORS FROM AROUND THE REGION - AND AROUND THE WORLD.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Curt Bailey President & CEO | OfficerTrustee | 40 | $765,282 |
Jose Lopez MD Chief Scientific Officer | Officer | 40 | $362,984 |
Theresa Nester MD Co-Chief Medical Officer Med Svcs | Officer | 40 | $338,626 |
Kirsten Alcorn Co-Chief Medical Officer Med Svcs | Officer | 40 | $334,615 |
Robert Gleason Treasurer & CFO | Officer | 40 | $284,316 |
David Lin MD Executive Director | 40 | $294,122 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
Alpha Media Llc Marketing Consulting | 6/29/22 | $500,500 |
Media Plus Marketing Consulting | 6/29/22 | $534,691 |
Degree 37 Llc Consulting | 6/29/22 | $500,187 |
Blood Bank Computer Systems Software Services | 6/29/22 | $358,231 |
Reliable Commercial Cleaning Inc Commercial Cleaning Services | 6/29/22 | $347,845 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $169,219 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $705,998 |
Noncash contributions included in lines 1a–1f | $19,662 |
Total Revenue from Contributions, Gifts, Grants & Similar | $875,217 |
Total Program Service Revenue | $132,170,114 |
Investment income | $1,045,353 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $623,063 |
Net Gain/Loss on Asset Sales | -$395,787 |
Net Income from Fundraising Events | -$4,622 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $134,313,338 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $459,516 |
Grants and other assistance to domestic individuals. | $438,300 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $3,718,972 |
Compensation of current officers, directors, key employees. | $1,622,956 |
Compensation to disqualified persons | $69,690 |
Other salaries and wages | $57,572,873 |
Pension plan accruals and contributions | $3,639,377 |
Other employee benefits | $6,031,000 |
Payroll taxes | $4,970,202 |
Fees for services: Management | $0 |
Fees for services: Legal | $247,904 |
Fees for services: Accounting | $82,337 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $14,500 |
Fees for services: Investment Management | $118,813 |
Fees for services: Other | $3,416,553 |
Advertising and promotion | $2,527,931 |
Office expenses | $3,309,340 |
Information technology | $4,571,964 |
Royalties | $0 |
Occupancy | $7,424,747 |
Travel | $161,275 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $188,614 |
Interest | $130,951 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $6,124,311 |
Insurance | $1,231,989 |
All other expenses | $0 |
Total functional expenses | $136,370,220 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $0 |
Savings and temporary cash investments | $15,800,704 |
Pledges and grants receivable | $1,225,567 |
Accounts receivable, net | $19,529,582 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $3,102,986 |
Prepaid expenses and deferred charges | $2,326,785 |
Net Land, buildings, and equipment | $34,400,768 |
Investments—publicly traded securities | $23,043,659 |
Investments—other securities | $0 |
Investments—program-related | $525,000 |
Intangible assets | $0 |
Other assets | $507,110 |
Total assets | $100,462,161 |
Accounts payable and accrued expenses | $15,552,071 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $10,000,000 |
Other liabilities | $0 |
Total liabilities | $25,552,071 |
Net assets without donor restrictions | $70,911,160 |
Net assets with donor restrictions | $3,998,930 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $100,462,161 |
Over the last fiscal year, Bloodworks has awarded $459,516 in support to 12 organizations.
Grant Recipient | Amount |
---|---|
REGENTS OF THE UNIVERSITY OF COLORADO PURPOSE: VON WILLEBRAND FACTOR IN PREGNANCY (VIP) STUDY | $11,000 |
OREGON HEALTH SCIENCES UNIVERSITY PURPOSE: VON WILLEBRAND FACTOR IN PREGNANCY (VIP) STUDY | $11,000 |
UNIVERSITY OF WASHINGTON PURPOSE: COMPREHENSIVE CHARACTERIZATION OF MISSENSE MUTANTS IN FACTOR IX | $248,262 |
UNIVERSITY OF WASHINGTON PURPOSE: MOLECULAR AND TRANSLATIONAL STUDIES IN HEMATOLOGIC DISORDERS | $57,658 |
UNIVERSITY OF UTAH PURPOSE: VON WILLEBRAND FACTOR IN PREGNANCY (VIP) STUDY | $13,000 |
BAYLOR COLLEGE OF MEDICINE PURPOSE: WILLEBRAND FACTOR IN TRAUMATIC BRAIN INJURY | $30,227 |